-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Anika Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Anika Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$28M, a 265% decline year-over-year.
- Anika Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$96.7M, a 217% decline year-over-year.
- Anika Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$87.6M, a 352% decline from 2022.
- Anika Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$19.4M, a 842% decline from 2021.
- Anika Therapeutics, Inc. annual Operating Income (Loss) for 2021 was $2.62M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)